| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 10/13/2004 | EP1165533B1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 10/13/2004 | EP1150954B1 Anti-imflammatory indole derivatives |
| 10/13/2004 | EP1131340B1 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis |
| 10/13/2004 | EP1097142B1 Phthalazine derivatives phosphodiesterase 4 inhibitors |
| 10/13/2004 | EP1086086B1 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 10/13/2004 | EP0840616B1 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases |
| 10/13/2004 | EP0817847B1 Il-17 receptor |
| 10/13/2004 | EP0802912B1 Piperidine derivatives having tachykinin antagonist activity |
| 10/13/2004 | EP0736036B1 Kininogen inhibitors |
| 10/13/2004 | CN1537111A Urea substituted imidazoquinolines |
| 10/13/2004 | CN1537105A Quinazolines as MMP-13 inhibitors |
| 10/13/2004 | CN1537104A Pyrimidine derivatives useful as selective COX-2 inhibitors |
| 10/13/2004 | CN1537101A Pyridine matrix metalloproteinase inhibitors |
| 10/13/2004 | CN1537100A Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives |
| 10/13/2004 | CN1537094A Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities |
| 10/13/2004 | CN1537025A 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1.1-dioxo-1 lambda b-thiomorpholin-4-yl)-4-(methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-N-methyl-isobutyramide |
| 10/13/2004 | CN1537019A Medical combination of aldosterone receptor antagonist and HMG CoA reductase inhibitor |
| 10/13/2004 | CN1537017A Remedie for inflammatory bowel diseases |
| 10/13/2004 | CN1537009A Method for treating or preventing functional vitamin B12 dificiency in individual and to medical compositions for use in said method |
| 10/13/2004 | CN1537006A Drug combination for treatment of headache comprising mirtazapine and paracetamol or non-steroidal anti-inflammatory drug |
| 10/13/2004 | CN1537003A Pharmaceutical composition comprising tricyclic compound for prevention or treatment of skin diseases |
| 10/13/2004 | CN1537002A Novel theterocyclic analogs of diphenylethylene compounds |
| 10/13/2004 | CN1537000A Novel imidazolidine derivatives, their preparation and their use as VLA-4 antagonists |
| 10/13/2004 | CN1536996A (-)-olivil as antioxidant |
| 10/13/2004 | CN1536991A (f)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 10/13/2004 | CN1536989A Oral compositions comprising host-respones modulating agent for promoting whole body health |
| 10/13/2004 | CN1536988A Sustained-release delivery system |
| 10/13/2004 | CN1535969A Total alkaloid of xiatianwu (a Chinese medicinal material), its preparation method and application |
| 10/13/2004 | CN1535968A Tetrahydro pyridyl or pyridyl heterocycle derivative |
| 10/13/2004 | CN1535961A Non-sterioid inflammation-resisting compound |
| 10/13/2004 | CN1535727A Mixed polypeptide vaccine, its preparation and application |
| 10/13/2004 | CN1535716A Medicine for external application for curing rheumatism and its preparation method |
| 10/13/2004 | CN1535707A Isatis root extract composition, its preparation method and application |
| 10/13/2004 | CN1535704A Fresh Chinese medicine preparation for external application for mainly curing ankylosing spondylitis |
| 10/13/2004 | CN1535692A Nitrogen oxide for curing inplammation |
| 10/13/2004 | CN1535684A Aconitum kusnezoffii methylsine powder injection preparation and its preparation method |
| 10/13/2004 | CN1535683A Aconitum kusnezoffii methylsine aerosol and its preparation method |
| 10/13/2004 | CN1170931C Vasculogenesis correlation molecule |
| 10/13/2004 | CN1170849C Connective tissue growth factor fragments and methods and uses thereof |
| 10/13/2004 | CN1170823C [5-chloro-6-phenyl-2-(4-trifluoromethylphenyl)-4-pyrimidinyl amino] acetamide derivatives, process for producing the same, medicinal compositions the same and internediate of these compounds |
| 10/13/2004 | CN1170811C Branched chain amino acid-dependent aminotransferase inhibitors and their use in treatment of diabetic retinopathy |
| 10/13/2004 | CN1170592C New use of melagatran |
| 10/13/2004 | CN1170589C The use of erythropoietin and iron preparations for producing pharmaceutical combination preparations for treating rheumatic diseases |
| 10/13/2004 | CN1170583C Weilingxian wine |
| 10/13/2004 | CN1170566C Externally applied pain-reliveing plaster and its prepn |
| 10/13/2004 | CN1170553C Medicinal wine for treating rheumatic and rheumatoid diseases |
| 10/13/2004 | CN1170548C Pain relieving ointment and its preparation |
| 10/13/2004 | CN1170538C Farnesyl protein transferase inhibitors for treating arthropathies |
| 10/13/2004 | CN1170537C Substituted 1-(piperidin-4-yl)3-(aryl)-isothioureas, ther prepn. and therapeutic use |
| 10/13/2004 | CN1170530C Patch containing 4-biphenylacetic acid |
| 10/12/2004 | USRE38624 Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and process for their preparation |
| 10/12/2004 | US6803481 Treating different types and symptoms of acute and chronic pain, especially non neuropathic inflammatory pain in mammals. the pain to be treated may be e.g. chronic inflammatory pain, rheumatoid arthritis pain and/or secondary |
| 10/12/2004 | US6803463 Process for the preparation of pyrazolopyridine derivatives |
| 10/12/2004 | US6803384 Diaminopropionic acid derivatives |
| 10/12/2004 | US6803380 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them |
| 10/12/2004 | US6803372 Such as cis-n-(4-benzoylphenyl)-4-hydroxy-3'-oxospiro (cyclohexane-1,1' (3'h)-isobenzofuran)-4-carboxamide for use as neuropeptide y receptor antagonist for treatment bulimia, obesity or diabetes |
| 10/12/2004 | US6803364 Il-5 inhibiting 6-azauracil derivatives |
| 10/12/2004 | US6803362 Heterocyclic compounds |
| 10/12/2004 | US6803359 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs |
| 10/12/2004 | US6803211 Cancer therapy |
| 10/12/2004 | US6803031 Aerosol comprises particles comprising at least 10 percent by weight of an erectile dysfunction drug, such as sildenafil, tadalafil or vardenafil. |
| 10/12/2004 | CA2170394C Process for conditioning substances |
| 10/07/2004 | WO2004085642A1 Arthritis-associated gene and use thereof in examining arthritis |
| 10/07/2004 | WO2004085452A1 Compound having affinity with calcified tissue |
| 10/07/2004 | WO2004085423A1 Piperidine derivatives for the treatment of chemokine or h1 mediated disease state |
| 10/07/2004 | WO2004085409A2 Compounds and libraries of pyridines, pyrazines, imidazo[1,2-a]pyrazines and 1h-imidazo[4,5-b]pyrazin-2-ones and first and second medical uses thereof |
| 10/07/2004 | WO2004085384A2 Bis-aryl sulfonamides |
| 10/07/2004 | WO2004084943A1 Use of antagonists of ghrelin or ghrelin receptor to treat intestinal inflammation |
| 10/07/2004 | WO2004084933A1 Elevation of adenosine level by cytokine-induced expression of cd73 |
| 10/07/2004 | WO2004084920A2 Anti-inflammatory treatment based on strontium compounds |
| 10/07/2004 | WO2004084891A1 Methods for treating inflammatory conditions or inhibiting jnk |
| 10/07/2004 | WO2004084874A2 Mtp inhibitors for inhibiting inflammation |
| 10/07/2004 | WO2004084873A1 Oral delivery system comprising an antibacterial and an anti-inflammatory agent |
| 10/07/2004 | WO2004084822A2 Methods for inducing immune tolerance |
| 10/07/2004 | WO2004069999A3 Screening method |
| 10/07/2004 | WO2004054514A3 C-6 modified indazolylpyrrolotriazines |
| 10/07/2004 | WO2004012659A3 Nitrosated proton pump inhibitors, compositions and methods of use |
| 10/07/2004 | WO2004002418A3 Compositions and methods comprising protein activated receptor antagonists |
| 10/07/2004 | WO2003099195A3 Immunomodulatory compounds and methods of use thereof |
| 10/07/2004 | WO2003049679A3 Mitotic kinesin inhibitors |
| 10/07/2004 | WO2002088317A3 Fusion molecules and methods for treatment of immune diseases |
| 10/07/2004 | WO2002083059A3 Use of esters of long-chain fatty acids for treatment of autoimmune diseases |
| 10/07/2004 | US20040198982 such as (4S)-1-(3-bromophenyl)-N-cyanomethyl)-4-methyl-prolinamide; for treatment of osteoporosis |
| 10/07/2004 | US20040198980 Selective rxr ligands |
| 10/07/2004 | US20040198979 antagonists of urotensin II; (R) N-[4-Chloro-3-(1-methyl-3-pyrrolidinyloxy)-phenyl]-[3-(2-chlorophenoxy)]benzenesulfonamide for example; treating various disease including cardiovascular disorders, gastrointestinal disorders, and psychological disorders |
| 10/07/2004 | US20040198961 Fce fusion proteins for treatment of allergy and asthma |
| 10/07/2004 | US20040198843 mixture of hydrophobic and polarity moiety; high pressure homogenization of crude oil and water |
| 10/07/2004 | US20040198824 enzyme inhibitor; anticancer agents; analgesics; vision defects |
| 10/07/2004 | US20040198801 Antiinflammatory agents; sepsis |
| 10/07/2004 | US20040198791 Fused imidazole derivative |
| 10/07/2004 | US20040198781 Carbonic anhydrase inhibitor |
| 10/07/2004 | US20040198766 Chemical compounds |
| 10/07/2004 | US20040198761 reducing pain; side effect reduction; plant extracts |
| 10/07/2004 | US20040198757 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 10/07/2004 | US20040198740 Therapies relating to combinations of aldose reductase inhibitors and cyclooxygenase-2 |
| 10/07/2004 | US20040198737 Azaindoles |
| 10/07/2004 | US20040198735 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 10/07/2004 | US20040198730 Pyridylfurans and pyrroles as raf kinase inhibitors |
| 10/07/2004 | US20040198720 3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 10/07/2004 | US20040198719 Antagonist of MCP-1 function, and compositions and methods of use thereof |